1. The current status and future perspectives of clinical trial groups in Japan

   • Hirofumi Mukai

   Special Feature 24 August 2013 Pages: 285 - 286

2. The current status and future perspectives of CSPOR-BC

   • Tomohiko Aihara
   • Hirofumi Mukai

   Special Feature 28 June 2012 Pages: 287 - 290

3. An overview of the Japan Breast Cancer Research Group (JBCRG) activities

   • Shinji Ohno
   • Katsumasa Kuroi
   • Masakazu Toi

   Special Feature Open access 15 March 2013 Pages: 291 - 295

4. Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan

   • Shozo Ohsumi
   • Kojiro Shimozuma

   Special Feature 09 May 2012 Pages: 296 - 301

5. Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer

   • Toru Watanabe

   Special Feature Open access 01 March 2013 Pages: 302 - 309

   

6. Harms of screening mammography for breast cancer in Japanese women

   • Yoshio Kasahara
   • Masaaki Kawai
   • Noriaki Ohuchi

   Original Article 27 January 2012 Pages: 310 - 315

   

7. Is MRI useful for the prediction of nipple involvement?

   • Naomi Sakamoto
   • Mitsuhiro Tozaki
   • Eisuke Fukuma

   Original Article 07 February 2012 Pages: 316 - 322

   

8. Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy

   • Naoko Honma
   • Rie Horii
   • Futoshi Akiyama

   Original Article 04 February 2012 Pages: 323 - 330

   

9. Pathological assessment of microinvasive carcinoma of the breast

   • Miki Mori
   • Koichiro Tsugawa
   • Seigo Nakamura

   Original Article 07 March 2012 Pages: 331 - 335

   

10. Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients

    • Rikiya Nakamura
    • Naohito Yamamoto
    • Masaru Miyazaki

    Original Article 25 February 2012 Pages: 336 - 341

11. A clinically relevant bi-cellular murine mammary tumor model as a useful tool for evaluating the effect of retinoic acid signaling on tumor progression

    • Laura Beatriz Todaro
    • María José Veloso
    • Elisa Dora Bal de Kier Joffé

    Original Article 29 February 2012 Pages: 342 - 356

    

12. A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

    • Pramod K. Julka
    • Raju T. Chacko
    • Tarun Puri

    Original Article 22 February 2012 Pages: 357 - 362

    

13. Primary pure signet cell carcinoma of the breast: a case report and review of the literature

    • Pinar Karabagli
    • Huseyin Kilic

    Case Report 17 June 2010 Pages: 363 - 366

    

14. Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer

    • Yoshimi Ide
    • Yoshinori Ito
    • Kiyohiko Hatake

    Case Report 24 July 2010 Pages: 367 - 370

    

15. Acknowledgement to reviewers 2013

    Acknowledgment 08 October 2013 Pages: 371 - 372